Project Number 1R43AG069552-01A1 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for ApoE isoform-specific glycosylation as diagnostic and prognostic biomarker of Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 6. Emerging Biomarkers b. Proteomic Researcher and Organization Principal Investigator NEDELKOV, DOBRIN Principal Investigator First Name DOBRIN Principal Investigator Last Name NEDELKOV Awardee Organization ISOFORMIX, INC. Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PA-19-272: PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed FY Overall Cost $250,562 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official LUO, YUAN
